Induction of β2-integrin mediated cell adhesion by β1-integrin engagement
Preincubation . | Blocking mAb . | Adhesion to ligands . | ||||||
---|---|---|---|---|---|---|---|---|
β2-integrins . | β1-integrins . | |||||||
KLH . | Fibrinogen . | ICAM-1 . | Fibronectin . | Laminin . | Collagen . | VCAM-1 . | ||
Medium | No mAb | 0.14 ± 0.01 | 0.13 ± 0.01 | 0.22 ± 0.05 | 0.31 ± 0.10 | 0.29 ± 0.03 | 0.24 ± 0.02 | 0.22 ± 0.05 |
Anti-β2 | 0.09 ± 0.02 | 0.12 ± 0.02 | 0.17 ± 0.01 | 0.37 ± 0.12 | 0.31 ± 0.05 | 0.24 ± 0.03 | 0.25 ± 0.04 | |
Anti-α4 | 0.14 ± 0.01 | 0.14 ± 0.01 | 0.23 ± 0.04 | 0.27 ± 0.12 | 0.30 ± 0.04 | 0.25 ± 0.03 | 0.20 ± 0.04 | |
mAb K20 | No mAb | 0.29 ± 0.05 | 0.27 ± 0.03 | 0.39 ± 0.05 | 0.37 ± 0.04 | 0.26 ± 0.04 | 0.25 ± 0.04 | 0.24 ± 0.05 |
Anti-β2 | 0.07 ± 0.02 | 0.08 ± 0.01 | 0.17 ± 0.07 | 0.43 ± 0.05 | 0.27 ± 0.06 | 0.24 ± 0.05 | 0.25 ± 0.05 | |
Anti-α4 | 0.27 ± 0.04 | 0.26 ± 0.04 | 0.41 ± 0.06 | 0.34 ± 0.06 | 0.23 ± 0.03 | 0.23 ± 0.04 | 0.21 ± 0.04 |
Preincubation . | Blocking mAb . | Adhesion to ligands . | ||||||
---|---|---|---|---|---|---|---|---|
β2-integrins . | β1-integrins . | |||||||
KLH . | Fibrinogen . | ICAM-1 . | Fibronectin . | Laminin . | Collagen . | VCAM-1 . | ||
Medium | No mAb | 0.14 ± 0.01 | 0.13 ± 0.01 | 0.22 ± 0.05 | 0.31 ± 0.10 | 0.29 ± 0.03 | 0.24 ± 0.02 | 0.22 ± 0.05 |
Anti-β2 | 0.09 ± 0.02 | 0.12 ± 0.02 | 0.17 ± 0.01 | 0.37 ± 0.12 | 0.31 ± 0.05 | 0.24 ± 0.03 | 0.25 ± 0.04 | |
Anti-α4 | 0.14 ± 0.01 | 0.14 ± 0.01 | 0.23 ± 0.04 | 0.27 ± 0.12 | 0.30 ± 0.04 | 0.25 ± 0.03 | 0.20 ± 0.04 | |
mAb K20 | No mAb | 0.29 ± 0.05 | 0.27 ± 0.03 | 0.39 ± 0.05 | 0.37 ± 0.04 | 0.26 ± 0.04 | 0.25 ± 0.04 | 0.24 ± 0.05 |
Anti-β2 | 0.07 ± 0.02 | 0.08 ± 0.01 | 0.17 ± 0.07 | 0.43 ± 0.05 | 0.27 ± 0.06 | 0.24 ± 0.05 | 0.25 ± 0.05 | |
Anti-α4 | 0.27 ± 0.04 | 0.26 ± 0.04 | 0.41 ± 0.06 | 0.34 ± 0.06 | 0.23 ± 0.03 | 0.23 ± 0.04 | 0.21 ± 0.04 |
Myelomonocytic HL60 cells were pretreated with mAb anti-β1 (K20) or control IgG (10 μg/mL each) for 30 minutes at 37°C. Cells were washed and added to the wells precoated with the specific β2-integrin ligands keyhole limpet hemocyanin (KLH), fibrinogen, or human recombinant ICAM-1, or with β1-integrin ligands fibronectin, laminin, collagen, or human recombinant VCAM-1. Adhesion was performed in the presence or absence of blocking mAbs anti-β2 (60.3), or anti-α4 (HP2.1) (20 μg/mL each). The assay was performed as described in “Materials and methods.” Values are displayed as mean absorbance ± SEM of at least 3 independent experiments. Brackets indicate significant differences (P < .01).